Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Lecithin organogels could be good for applying drugs to the skin because they are stable, safe, and can improve drug absorption.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

FFA's causes may include environmental triggers and genetic factors.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Some birth control pills have a higher risk of blood clots than others.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.